A 2025 meta-analysis combined 151 studies on interventions for advanced maternal age (>35) patients. It found no clear advantage to any specific stimulation protocol or FSH type, no benefit from routine ICSI, and decreased live birth with assisted hatching, while more research is needed on blastocyst versus cleavage-stage transfer and on PGT-A with modern methods.
The Italian Society of Fertility and Sterility and Reproductive Medicine (SIFES-MR) has issued new guidelines on 28 IVF add-ons, outlining which may help in certain situations, which lack evidence, and which should be limited to research.
The ASRM has released their 2024 committee opinion on the use of PGT-A, covering the use of PGT-A for patients with a good prognosis, advanced age, donor eggs, recurrent pregnancy loss and more.
Researchers in a 2023 study combined the results of 74 studies to investigate what factors contribute to euploid live birth and miscarriage rates, identifying embryo quality, maternal age, specific diagnoses, repeat freeze/thaw, and other factors.
Researchers in a 2021 review combined multiple studies on assisted hatching and found no clear improvement in live birth rates, though clinical pregnancy rates were slightly higher and the chance of multiple pregnancy increased.
